Hypotension, syncope, and fever in systemic mastocytosis without skin infiltration and rapid response to corticosteroid and cyclosporin: A case report

Case Reports in Medicine

Volumn 2010, Issue , 2010, Pages

  Ozdemir, Didem ^a   Dagdelen, Selcuk ^a   Erbas, Tomris ^a   Agbaht, Kemal ^a   Serefhanoglu, Songul ^a   Aksu, Salih ^a   Ersoy Evans, Sibel ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85021411594     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2010/782595     Document Type: Article

References (21)

1. H. P. Horny, K. Sotlar, and P. Valent, "Mastocytosis: state of the art," Pathobiology, vol. 74, no. 2, pp. 121-132, 2007.
2. A. Tefferi and J. W. Vardiman, "Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms," Leukemia, vol. 22, no. 1, pp. 14-22, 2008.
3. C. Akin and D. D. Metcalfe, "Systemic mastocytosis," Annual Review of Medicine, vol. 55, pp. 419-432, 2004.
4. L. Golkar and J. D. Bernhard, "Mastocytosis," The Lancet, vol. 349, no. 9062, pp. 1379-1385, 1997.
5. L. Marbello, M. Anghilieri, A. Nosari et al., "Aggressive systemic mastocytosis mimicking sclerosing cholangitis," Haematologica, vol. 89, no. 9, p. ECR35, 2004.
6. R. S. Fishman, C. R. Fleming, and C. Y. Li, "Systemic mastocytosis with review of gastrointestinal manifestations," Mayo Clinic Proceedings, vol. 54, no. 1, pp. 51-54, 1979.
7. P. Valent, C. Akin, L. Escribano et al., "Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria," European Journal of Clinical Investigation, vol. 37, no. 6, pp. 435-453, 2007. (Pubitemid 46817344)
8. K. H. Lim, A. Tefferi, T. L. Lasho et al., "Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors," Blood, vol. 113, no. 23, pp. 5727-5736, 2009.
9. H. C. Kluin-Nelemans, J. M. Oldhoff, J. J. van Doormaal et al., "Cladribine therapy for systemic mastocytosis," Blood, vol. 102, no. 13, pp. 4270-4276, 2003.
10. P. Valent, C. Akin, W. R. Sperr et al., "Mastocytosis: pathology, genetics, and current options for therapy," Leukemia and Lymphoma, vol. 46, no. 1, pp. 35-48, 2005.
11. L. B. Schwartz, "Tryptase: a clinical indicator of mast cell-dependent events," Allergy Proceedings, vol. 15, no. 3, pp. 119-123, 1994.
12. P. Valent, C. Akin, W. R. Sperr, H. P. Horny, and D. D. Metcalfe, "Mast cell proliferative disorders: current view on variants recognized by the World Health Organization," Hematology/Oncology Clinics of North America, vol. 17, no. 5, pp. 1227-1241, 2003. (Pubitemid 37187806)
13. J. H. Butterfield, A. Tefferi, and G. F. Kozuh, "Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case," Leukemia Research, vol. 29, no. 2, pp. 131-134, 2005. (Pubitemid 39647505)
14. P. Casassus, N. Caillat-Vigneron, A. Martin et al., "Treatment of adult systemic mastocytosis with interferon-α: results of a multicentre phase II trial on 20 patients," British Journal of Haematology, vol. 119, no. 4, pp. 1090-1097, 2002. (Pubitemid 35463838)
15. B. Hennessy, F. Giles, J. Cortes et al., "Management of patients with systematic mastocytosis: review of M. D. Anderson Cancer Center experience," American Journal of Hematology, vol. 77, no. 3, pp. 209-214, 2004. (Pubitemid 39430697)
16. E. Delaporte, E. Pierard, B. G. Wolthers et al., "Interferon-α in combination with corticosteroids improves systemic mast cell disease," British Journal of Dermatology, vol. 132, no. 3, pp. 479-482, 1995.
17. A. Tefferi, C. Y. Li, J. H. Butterfield, and H. C. Hoagland, "Treatment of systemic mast-cell disease with cladribine," The New England Journal of Medicine, vol. 344, no. 4, pp. 307-309, 2001. (Pubitemid 32108542)
18. H. J. Droogendijk, H. J. C. Kluin-Nelemans, J. J. van Doormaal, A. P. Oranje, A. A. van de Loosdrecht, and P. L. A. van Daele, "Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial," Cancer, vol. 107, no. 2, pp. 345-351, 2006.
19. A. Tefferi and A. Pardanani, "Systemic mastocytosis: current concepts and treatment advances," Current Hematology Reports, vol. 3, no. 3, pp. 197-202, 2004.
20. A. Vega-Ruiz, J. E. Cortes, M. Sever et al., "Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis," Leukemia Research, vol. 33, no. 11, pp. 1481-1484, 2009.
21. M. Kurosawa, H. Amano, N. Kanbe et al., "Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis," Journal of Allergy and Clinical Immunology, vol. 103, no. 5, pp. S412-S420, 1999. (Pubitemid 29296015)